Evaluation of Docetaxel-Sensitive and Docetaxel-Resistant Proteomes in PC-3 Cells.

Shulu Zu,Weiming Ma,Pan Xiao,Yazhou Cui,Tianjia Ma,Chunwen Zhou,Huaiqiang Zhang

Evaluation of Docetaxel-Sensitive and Docetaxel-Resistant Proteomes in PC-3 Cells.

2015

Shulu Zu
Weiming Ma
Pan Xiao
Yazhou Cui
Tianjia Ma
Chunwen Zhou
Huaiqiang Zhang

Objectives: Docetaxel was the first drug with proven survival benefit in men with castration-resistant prostate cancer. Acquired resistance to docetaxel precedes

Keywords:

Drug resistance
Prostate cancer
Medicine
Pharmacology
Docetaxel
Drug
Oncology
survival benefit
acquired resistance
Internal medicine
Proteome

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations